Licensing Opportunities

Unlock the potential of BraineHealth’s US Patent 11,908,579 B2 with Diagnosio’s 99% accurate AI diagnostics.

Our inversion technology, featured in USA News, BizWeekly and AP across 450+ outlets, scales to 20,000+ cases and 200,000 observables, outperforming Microsoft’s MAI-DxO.

License this innovation for healthcare, finance, or engineering, targeting the $500B AI market by 2032.

Licensing Benefits:

Revenue Growth: Monetize a patented AI solution with global demand.

Tech Advantage: Integrate 99% accuracy into your operations.

License the Patent* | Contact Us to collaborate.

*Discussions regarding licensing the patent must occur exclusively through Vibrant IP